Request for Information (RFI) and Industry Day Announcement: Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors
Closed Pre-Solicitation Posted
- Solicitation number
- W911SR-25-S-ACHE
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Frederick, Maryland 21702, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), operating through the Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground, has issued a Request for Information to survey industry capabilities for developing broad spectrum prophylactics against acetylcholinesterase inhibitors. The government seeks solutions that can neutralize these chemical agents before they impact nervous system targets, focusing on engineering, testing, and manufacturing capabilities. This RFI serves purely for planning purposes and does not constitute a government commitment or guarantee future solicitation issuance. The information collected will be shared with relevant government parties to inform future development and procurement strategies. Responses to this RFI are due by October 8, 2025, with an associated Industry Day announcement providing additional details on performance objectives and information requirements.
This procurement opportunity operates without any set-aside designations, making it open to all qualified contractors. The notice does not identify any incumbent contractors or provide specific award values or budget ranges, as this is an information-gathering exercise rather than an active solicitation. No contract quantities, service timelines, or numerical performance metrics are specified in the current RFI documentation. The government emphasizes that no payment will be provided for information submitted in response to this request. The opportunity falls under NAICS code 541715 for Research and Development in Physical, Engineering, and Life Sciences, and PSC code AN13 for Health R&D Services and Experimental Development, indicating the technical and scientific nature of the anticipated future procurement.
Notice text
This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited.
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) focus is to survey current industry capabilities in the engineering, testing, and manufacturing of solutions capable of neutralizing a broad spectrum of acetylcholinesterase (AChE) inhibitors before they affect nervous system targets. The information gathered by this RFI will be shared with relevant interested Government parties to help inform future development and procurement efforts.
No solicitation document exists or is guaranteed to be issued as a result of this RFI. Please see link below, to include RFI attachment, for a full list of performance objectives, industry day details and information requested.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity